R-Ras interacts with filamin a to maintain endothelial barrier function

Journal of Cellular Physiology

Volumn 226, Issue 9, 2011, Pages 2287-2296

  Griffiths, G S ^a   Grundl, M ^a   Allen, J S ^b   Matter, M L ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; ENZYME INHIBITOR; FILAMIN A; FLUORESCEIN ISOTHIOCYANATE; GGTI 2133; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PROTEIN KINASE P60; R RAS PROTEIN; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIAL BARRIER FUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

CADHERINS; CAPILLARY PERMEABILITY; CONTRACTILE PROTEINS; CORONARY VESSELS; CYTOSKELETON; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROFILAMENT PROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RAS PROTEINS; RNA, SMALL INTERFERING;

EID: 79958752739     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22565     Document Type: Article

References (52)

1. Andor A, Trulzsch K, Essler M, Roggenkamp A, Wiedemann A, Heesemann J, Aepfelbacher M. 2001. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell Microbiol 3: 301-310.
2. Bogatcheva NV, Zemskova MA, Kovalenkov Y, Poirier C, Verin AD. 2009. Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. J Cell Physiol 221: 750-759.
3. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213-232.
4. Borbiev T, Verin AD, Shi S, Liu F, Garcia JG. 2001. Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol 280: L983-L990.
5. Caraglia M, Budillon A, Tagliaferri P, Marra M, Abbruzzese A, Caponigro F. 2005. Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: Preclinical and clinical implications. Curr Drug Targets 6: 301-323.
6. Chen C, Jamaluddin MS, Yan S, Sheikh-Hamad D, Yao Q. 2008. Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 28: 906-912.
7. Clark PR, Manes TD, Pober JS, Kluger MS. 2007. Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations 2. J Invest Dermatol 127: 762-774.
8. Cole AL, Subbanagounder G, Mukhopadhyay S, Berliner JA, Vora DK. 2003. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway 2. ArteriosclerThrombVascBiol 23: 1384-1390.
9. Cukier IH, Li Y, Lee JM. 2007. Cyclin B1/Cdk1 binds and phosphorylates Filamin A and regulates its ability to cross-link actin. FEBS Lett 581: 1661-1672.
10. Dejana E, Orsenigo F, Lampugnani MG. 2008. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121: 2115-2122.
11. Dejana E, Tournier-Lasserve E, Weinstein BM. 2009. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev Cell 16: 209-221.
12. Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA. 2002. Src-mediated coupling of focal adhesion kinase to integrin alpha (v) beta5 in vascular endothelial growth factor signaling 2. J Cell Biol 157: 149-160.
13. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. 1998. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 273: 21867-21874.
14. Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F, Kwiatkowski DJ, Walsh CA. 2006. Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis 2. Proc Natl Acad Sci USA 103: 19836-19841.
15. Gavard J. 2009. Breaking the VE-cadherin bonds. FEBS Lett 583: 1-6.
16. Gawecka JE, Griffiths GS, Ek-Rylander B, Ramos JW, Matter ML. 2010. R-Ras regulates migration through an interaction with filamin A in melanoma cells. PLoS One 5: e11269.
17. Gonzalez AM, Bhattacharya R, deHart GW, Jones JC. 2010. Transdominant regulation of integrin function: Mechanisms of crosstalk. Cell Signal 22: 578-583.
18. Gorlin JB, Yamin R, Egan S, Stewart M, Stossel TP, Kwiatkowski DJ, Hartwig JH. 1990. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): A molecular leaf spring. J Cell Biol 111: 1089-1105.
19. Groeneveld AB. 2002. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vascul Pharmacol 39: 247-256.
20. Ha CH, Bennett AM, Jin ZG. 2008. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem 283: 7261-7270.
21. Holly SP, Larson MK, Parise LV. 2005. The unique N-terminus of R-ras is required for Rac activation and precise regulation of cell migration 1. Mol Biol Cell 16: 2458-2469.
22. Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH. 2003. Ras GTPases: Integrins' friends or foes? Natl Rev Mol Cell Biol 4: 767-776.
23. Kolosova IA, Mirzapoiazova T, Moreno-Vinasco L, Sammani S, Garcia JG, Verin AD. 2008. Protective effect of purinergic agonist ATPgammaS against acute lung injury. Am J Physiol Lung Cell Mol Physiol 294: L319-L324.
24. Komatsu M, Ruoslahti E. 2005. R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis 2. Nat Med 11: 1346-1350.
25. Kusama T, Mukai M, Tatsuta M, Nakamura H, Inoue M. 2006. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho. Int J Oncol 29: 217-223.
26. Kyndt F, Gueffet JP, Probst V, Jaafar P, Legendre A, Le BF, Toquet C, Roy E, McGregor L, Lynch SA, Newbury-Ecob R, Tran V, Young I, Trochu JN, Le MH, Schott JJ. 2007. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy 2. Circulation 115: 40-49.
27. Matter ML, Zhang Z, Nordstedt C, Ruoslahti E. 1998. The alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis. J Cell Biol 141: 1019-1030.
28. Mucha DR, Myers CL, Schaeffer RC, Jr., 2003. Endothelial contraction and monolayer hyperpermeability are regulated by Src kinase. Am J Physiol Heart Circ Physiol 284: H994-H1002.
29. Ohta Y, Hartwig JH. 1995. Actin filament cross-linking by chicken gizzard filamin is regulated by phosphorylation in vitro. Biochemistry 34: 6745-6754.
30. Petrache I, Crow MT, Neuss M, Garcia JG. 2003. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. Biochem Biophys Res Commun 306: 244-249.
31. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG. 2001. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 280: L1168-L1178.
32. Popoff MR, Geny B. 2009. Multifaceted role of Rho, Rac, Cdc42, and Ras in intercellular junctions, lessons from toxins. Biochim Biophys Acta 1788: 797-812.
33. Potter MD, Barbero S, Cheresh DA. 2005. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 280: 31906-31912.
34. Retta SF, Cassara G, D'Amato M, Alessandro R, Pellegrino M, Degani S, De Leo G, Silengo L, Tarone G. 2001. Cross talk between beta(1) and alpha(V) integrins: Beta(1) affects beta(3) mRNA stability. Mol Biol Cell 12: 3126-33138.
35. Sallee JL, Wittchen ES, Burridge K. 2006. Regulation of cell adhesion by protein-tyrosine phosphatases: II. Cell-cell adhesion. J Biol Chem 281: 16189-16192.
36. Schiestl RH, Gietz RD. 1989. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet 16: 339-346.
37. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, Reiss K. 2008. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 102: 1192-1201.
38. Serban D, Leng J, Cheresh D. 2008. H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors. Circ Res 102: 1350-1358.
39. Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA. 2004. The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279: 35679-35686.
40. Stockton RA, Shenkar R, Awad IA, Ginsberg MH. 2010. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207: 881-896.
41. Stossel TP, Hartwig JH. 2003. Filling gaps in signaling to actin cytoskeletal remodeling. Dev Cell 4: 444-445.
42. Sun J, Ohkanda J, Coppola D, Yin H, Kothare M, Busciglio B, Hamilton AD, Sebti SM. 2003. Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice. Cancer Res 63: 8922-8929.
43. Takaya A, Kamio T, Masuda M, Mochizuki N, Sawa H, Sato M, Nagashima K, Mizutani A, Matsuno A, Kiyokawa E, Matsuda M. 2007. R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes. Mol Biol Cell 18: 1850-1860.
44. Tinsley JH, Hunter FA, Childs EW. 2009. PKC and MLCK-Dependent, Cytokine-Induced Rat Coronary Endothelial Dysfunction. J Surg Res 152: 76-83.
45. Vaidyanathan H, Opoku-Ansah J, Pastorino S, Renganathan H, Matter ML, Ramos JW. 2007. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15 1. Proc Natl Acad Sci USA 104: 19837-19842.
46. van Nieuw Amerongen GP, van Hinsbergh VW. 2007. Endogenous RhoA inhibitor protects endothelial barrier. Circ Res 101: 7-9.
47. Wang B, Zou JX, Ek-Rylander B, Ruoslahti E. 2000. R-Ras contains a proline-rich site that binds to SH3 domains and is required for integrin activation by R-Ras. J Biol Chem 275: 5222-5227.
48. Weis SM, Cheresh DA. 2005. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497-504.
49. Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ. 2001. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114: 1343-1355.
50. Wojciak-Stothard B, Ridley AJ. 2002. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 39: 187-199.
51. Zhang Z, Vuori K, Wang H, Reed JC, Ruoslahti E. 1996. Integrin activation by R-ras 2. Cell 85: 61-69.
52. Zhou X, Boren J, Akyurek LM. 2007. Filamins in cardiovascular development 1. Trends Cardiovasc Med 17: 222-229.